British American Tobacco


25/03/24 -"We have integrated BAT’s FY 2023 results into our model and revised downwards our estimates for FY 2024 and FY 2025. Theses changes are mainly explained by i) higher financial expenses, at c.€1.8bn ..."

Pages
48
Language
English
Published on
25/03/24
You may also be interested by these reports :
11/07/24
The Q1 results did not bring any significant surprises. The yoy decline in profitability had been expected and was already factored into our ...

11/07/24
Solid 3Q/9-months results but the figures do not answer the key questions of the investment case

10/07/24
Not surprisingly, Remy Cointreau’s situation is not improving. In China, the market remains subdued. With a likely inevitable increase in cognac ...

10/07/24
For FY25 (closing in Jun-2025), our main changes are due to the Chinese anti-dumping investigation. With the rise in commercial tensions between the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO